SHL Telemedicine Ltd American Depositary Shares (SHLT) — Capital Reinvestment Ratio

Latest as of December 2023: 1.57x

SHL Telemedicine Ltd American Depositary Shares (SHLT) has a Capital Reinvestment Ratio of 1.57x as of December 2023, meaning it reinvests 2% of its operating cash flow ($1.76 Million) in capital expenditures ($2.77 Million). See how much free cash does SHL Telemedicine Ltd American Depositary generate to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

1.57x
Capex / Operating Cash Flow

Operating Cash Flow

$1.76 Million
USD

Capital Expenditures

$2.77 Million
USD

Data as of

Dec 2023
Most recent filing

SHL Telemedicine Ltd American Depositary Shares Capital Reinvestment Ratio (2002–2021)

This chart tracks SHL Telemedicine Ltd American Depositary Shares's Capital Reinvestment Ratio across 14 annual periods.

Annual Capital Reinvestment Ratio for SHL Telemedicine Ltd American Depositary Shares (2002–2021)

Year-by-year Capital Reinvestment Ratio for SHL Telemedicine Ltd American Depositary Shares from 2002 to 2021. For live market cap and broader valuation context, see SHLT stock market capitalisation.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2021 17.61x $185.00K $3.26 Million ▲ +4553.1%
2020 0.38x $4.68 Million $1.77 Million ▲ +108.0%
2019 0.18x $10.85 Million $1.97 Million ▲ +86.1%
2018 0.10x $12.76 Million $1.25 Million ▼ -27.7%
2017 0.14x $11.84 Million $1.60 Million ▼ -80.4%
2015 0.69x $3.98 Million $2.75 Million ▼ -52.3%
2013 1.45x $2.81 Million $4.08 Million ▼ -46.9%
2012 2.73x $1.63 Million $4.43 Million ▲ +43.6%
2010 1.90x $3.01 Million $5.71 Million ▲ +43.5%
2009 1.32x $5.26 Million $6.96 Million ▼ -62.4%
2006 3.52x $1.80 Million $6.34 Million ▼ -26.8%
2004 4.81x $1.30 Million $6.27 Million ▼ -44.0%
2003 8.59x $645.00K $5.54 Million ▲ +313.7%
2002 2.08x $2.21 Million $4.60 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow